Veterinary researchers and Anivive license antiviral drug for fatal cat disease

Posted on September 20, 2018

A new collaboration at Kansas State University is promoting the commercial development of GC376, an antiviral compound for feline infectious peritonitis, or FIP, which previously has had no effective treatment or cure.

View article source to read more